In this issue:
- CX 2025: Cost-effectiveness outcomes defy expectations in latest BEST-CLI data drop
- Reality check: Study brings “significant” gap between randomised and real-world vascular patient populations into sharp focus
- In profile: Jacques Busquet (Paris, France)
- Interview: Gustavo Oderich (Houston, USA) speaks to Vascular News about his new role at Baylor College of Medicine and Texas Heart Institute
- Opinion: Adam Talbot (Manchester, UK) writes about “reframing success” in vascular surgery and embracing the increasingly palliative aspect of the specialty
